scispace - formally typeset
V

Valeria Raia

Researcher at University of Naples Federico II

Publications -  171
Citations -  7777

Valeria Raia is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Cystic fibrosis & Cystic fibrosis transmembrane conductance regulator. The author has an hindex of 42, co-authored 166 publications receiving 6303 citations. Previous affiliations of Valeria Raia include Istituto Superiore di Sanità & European Institute.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

Luigi Maiuri, +9 more
- 05 Jul 2003 - 
TL;DR: The findings emphasise the key role of gliadin-specific T cells, and suggest a complex pathogenic situation, and show that inhibition of interleukin-15 or p38 MAP kinase might have the potential to control coeliac disease.
Journal ArticleDOI

Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition

Alessandro Luciani, +18 more
- 01 Sep 2010 - 
TL;DR: It is shown how the defective CFTR results in defective autophagy and decreases the clearance of aggresomes, leading to the accumulation of protein aggregates and to lung inflammation.
Journal ArticleDOI

Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect.

Valeria Rachela Villella, +6 more
- 21 Jan 2013 - 
TL;DR: Recent pre-clinical evidence indicating that targeting the intracellular environment surrounding the misfolded mutant CFTR instead of protein itself could constitute an attractive therapeutic option to sensitize patients carrying the F508del-CFTR mutation to the beneficial action of CFTR potentiators on lung inflammation is reviewed.
Journal ArticleDOI

Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.

Eugenia Bruzzese, +6 more
- 01 Oct 2004 - 
TL;DR: To assess the incidence of intestinal inflammation in children with cystic fibrosis and to investigate whether probiotics decrease it, a study using probiotics and E.coli is presented.